For research use only. Not for therapeutic Use.
Oditrasertib is a receptor-interacting protein kinase 1 (RIPK1) inhibitor with an IC50 value lower than 100 nM. Oditrasertib can be used for the research of diseases involving inflammation or cell death[1].
| Catalog Number | I041970 |
| CAS Number | 2252271-93-3 |
| Synonyms | 4-(3,3-difluoro-2,2-dimethylpropanoyl)-3,5-dihydro-2H-pyrido[3,4-f][1,4]oxazepine-9-carbonitrile |
| Molecular Formula | C14H15F2N3O2 |
| Purity | ≥95% |
| InChI | InChI=1S/C14H15F2N3O2/c1-14(2,12(15)16)13(20)19-3-4-21-11-9(5-17)6-18-7-10(11)8-19/h6-7,12H,3-4,8H2,1-2H3 |
| InChIKey | CSCLQCHKUAMZOY-UHFFFAOYSA-N |
| SMILES | CC(C)(C(F)F)C(=O)N1CCOC2=C(C=NC=C2C1)C#N |
| Reference | [1]. Fidalgo JDV, et al. Preparation of substituted oxazepines and related compounds as RIPK1 inhibitors and uses thereof. WO2018213632A1. 2018-11-22. |
